Terms: = Lung cancer AND TCF3, E2A, 6929, ENSG00000071564, P15923, MGC129648, MGC129647, ITF1 AND Treatment
5 results:
1. Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients.
Higashiyama RI; Horinouchi H; Kuchiba A; Matsumoto Y; Murakami S; Goto Y; Kanda S; Fujiwara Y; Yamamoto N; Ohe Y
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3185-3191. PubMed ID: 35900471
[TBL] [Abstract] [Full Text] [Related]
2. A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven lung cancer.
Yochum ZA; Cades J; Mazzacurati L; Neumann NM; Khetarpal SK; Chatterjee S; Wang H; Attar MA; Huang EH; Chatley SN; Nugent K; Somasundaram A; Engh JA; Ewald AJ; Cho YJ; Rudin CM; Tran PT; Burns TF
Mol Cancer Res; 2017 Dec; 15(12):1764-1776. PubMed ID: 28851812
[TBL] [Abstract] [Full Text] [Related]
3. In silico identification of potential key regulatory factors in smoking-induced lung cancer.
El-Aarag SA; Mahmoud A; Hashem MH; Abd Elkader H; Hemeida AE; ElHefnawi M
BMC Med Genomics; 2017 Jun; 10(1):40. PubMed ID: 28592245
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of microRNA expression in completely resected lung adenocarcinoma and the associated response to erlotinib.
Yan G; Yao R; Tang D; Qiu T; Shen Y; Jiao W; Ge N; Xuan Y; Wang Y
Med Oncol; 2014 Oct; 31(10):203. PubMed ID: 25192889
[TBL] [Abstract] [Full Text] [Related]
5. Expression of WNT7A in human normal tissues and cancer, and regulation of WNT7A and WNT7B in human cancer.
Kirikoshi H; Katoh M
Int J Oncol; 2002 Oct; 21(4):895-900. PubMed ID: 12239632
[TBL] [Abstract] [Full Text] [Related]
